Population: Adults (18-64 years)

STIMULATE-ICP

United Kingdom of Great Britain and Northern Ireland
|
2022
  • Adults (18-64 years)
  • General population
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Colchicine
  • Antihistamines
  • Rivaroxaban

RECLAIM

The Netherlands
|
2025
  • Adults (18-64 years)
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Pharmacological intervention
  • Immunomodulator
  • Colchicine
  • Metformin

COVID COHORT – SPAIN

Spain
|
2020-2025
  • Adults (18-64 years)
  • General population
  • Hospital
  • SARS-CoV-2
  • Acute COVID-19
  • Blood sample
  • PBMC
  • Whole blood

ZIKAllianceCH

Bolivia (Plurinational State of) Brazil Colombia Guadeloupe Mexico Venezuela (Bolivarian Republic of)
|
2018-2022
  • Adults (18-64 years)
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Pregnant women
  • Community
  • Arbovirus
  • Vector-borne disease
  • Zika virus
  • Arboviral disease
  • Vector-borne disease
  • Blood sample
  • Urine sample
  • Hair
  • Saliva
  • Semen
  • Vaginal fluids

VaQDENV

Italy
|
2024-2028
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • Arbovirus
  • Dengue virus
  • Vector-borne disease
  • Arboviral disease
  • Vector-borne disease
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • Qdenga

SeVIHPrEP

Spain
|
2020-2030
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Mycoplasma genitalium
  • Hepatitis
  • Sexually transmitted infection
  • Anorectal swab
  • Oral swab
  • Urethral exudate
  • Pharmacological intervention
  • PrEP-HIV

EpGAr

France
|
2024-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Neisseria gonorrhoeae
  • Sexually transmitted infection

DanPrEPD

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • Antivirals
  • PrEP-HIV

Mondì

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Pregnant women
  • Hospital
  • Outpatient clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Sexually transmitted infection

Maldonado-Barrueco

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Hospital
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Mycoplasma genitalium
  • Trichomonas vaginalis
  • Sexually transmitted infection
  • Non pharmacological intervention
  • RT-PCR

Ganesh

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Emergency department
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Sexually transmitted infection
  • Non pharmacological intervention
  • RT-PCR